Octreotide Infusion Preparation
For continuous intravenous infusion, octreotide should be diluted in 50-200 mL of sterile isotonic saline or dextrose 5% in water and infused over 15-30 minutes, or administered as IV push over 3 minutes; in emergency situations such as carcinoid crisis, it may be given by rapid bolus. 1
Preparation Guidelines
Dilution and Compatibility
- Octreotide is stable in sterile isotonic saline or dextrose 5% solutions for 24 hours 1
- Dilute in volumes of 50-200 mL for infusion 1
- Do NOT mix octreotide in Total Parenteral Nutrition (TPN) solutions due to formation of glycosyl octreotide conjugate that decreases efficacy 1
- Inspect solution visually for particulate matter and discoloration before use; do not use if present 1
Administration Routes and Techniques
- Intravenous infusion: Administer over 15-30 minutes 1
- IV push: Can be given over 3 minutes 1
- Rapid bolus: Reserved for emergency situations like carcinoid crisis 1
- Use proper sterile technique to minimize microbial contamination 1
Dosing Regimens by Indication
Variceal Hemorrhage
- Initial IV bolus of 50 mcg followed by continuous infusion of 50 mcg/hour 2
- Can be used continuously for 5 days or longer 2
- Recent evidence suggests 24-hour infusion may be non-inferior to 72-hour infusion for preventing rebleeding 3
Carcinoid Crisis Prevention (Perioperative)
- 50 mcg/hour by continuous IV infusion for 12 hours prior to surgery and at least 48 hours after surgery 4
- This prevents life-threatening cardiorespiratory complications during tumor manipulation 4
Chemotherapy-Induced Diarrhea
- Start at 100-150 mcg subcutaneously or IV three times daily 5
- Can titrate up to 500 mcg three times daily or 25-50 mcg/hour by continuous IV infusion 5
- For refractory cases, continuous infusion regimen: 50 mcg/hour for 12 hours, then 100 mcg/hour for 12 hours, then 150 mcg/hour for 72 hours 6
- Higher doses (500 mcg three times daily) are more effective than lower doses (100 mcg three times daily) in loperamide-refractory cases 7
Acromegaly
- Initial dosing: 50 mcg three times daily, titrating upward based on IGF-1 levels 1
- Most effective dose: 100 mcg three times daily, though some require up to 500 mcg three times daily 1
Important Caveats
Drug Interactions
- Proton pump inhibitors, H2-receptor antagonists, and antacids decrease octreotide bioavailability 8
- Monitor patients on cyclosporine, insulin, antidiabetic drugs, digoxin, lisinopril, bromocriptine, beta-blockers, and calcium channel antagonists for dose adjustments 8
Monitoring Requirements
- Monitor for gastrointestinal symptoms (nausea, vomiting, diarrhea, abdominal discomfort) 8
- Watch for blood glucose changes, thyroid function abnormalities, bradycardia, and arrhythmias 8
- QTc monitoring not required (unlike domperidone), as octreotide does not affect QT interval 9